This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Bolger BS, Dabbas M, Monaghan JM (1997) Prognostic value of preoperative squamos cell karzinoma antigen level in patients surgically treated for cervical karzinoma. Gynecol Oncol 65: 309–313
Canizares F, Sola J, Pérez M, Tovar I, DeLasHeras M, Salinas J, Penafiel R, Martinez P (2001) Preoperative value of CA 15–3 and CEA as prognostic factors in breast cancer: a multivariate analysis. Tumori 22: 273–281
Copper BC, SoodAK, Davis CS, Ritchie JM, Sorosky Ji, Anderson B, Buller RE (2002) Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer. Obstet Gynecol 100: 59–64
Duk JM, Groenier KH, de Bruijn HW, Hollema H, Ten Hoor KA, van der Zee AG, Aalders JG (1996) Pretreatment serum squamous cell karzinoma antigen: a newly identified prognostic factor in early-stage cervical karzinoma. J Clin Oncol 1996: 111–118
Forslund A, Engaras B, Lonnroth C, Lundholm K (2002) Prediction of postoperative survival by preoperative concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal karzinoma. Int J Oncol 20: 1013–1018
Gaarenstroom KN, Kenter GG, Bonfrer JMG, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB (2000) Can initial serum Cyfra 21–1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastasis or prognosis. Gynecol Oncol 77: 164–170
Hsieh CH, ChangChien CC, Lin H, Huang EY, Huang CC, Lan KC, Chang SY (2002) Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol 86: 28–33
Jakobs IJ, Skates SJ, MacDonald N, Menon U, Rosenthal AN, Davies AP, Woolas R, Jeyarajah AR, Sibley K, Lowe DG, Oram DH (1999) Screening for ovarian cancer: a pilot randomised controlled trial. Lancet 353: 1207–1210
Kurihara T, Mizinuma H, Obara M, Andoh K, Ibuki Y, Nishimura T (1998) Determination of a normal level of serum AC 125 in postmenopausal women as a tool for preoperative evaluation and postopera-tive surveillance of endometrial karzinoma. Gyne-col Oncol 69: 192–196
MareIli D, Pinto E, DeStefano A, de Manzoni G, Farnetani M, Garosi L, Roviello F (2001) Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer. J Surg Oncol 78: 253–258
Miinstedt K, Krisch M, Sachsse S, Vahrson H (1997) Serum CA 125 levels and survival in advanced ova-rian cancer. Arch Gynecol Obstet 259: 117–123
Ron IG, Inbar M, Gelernter I, Lewysohn 0, Ayalon D, Dale J, Chatchik S (1994) Use of CA-125 response to predict survival parameters of patients with advan-ced ovarian karzinoma. Acta Obstet Gynecol Scand 73: 658–662
Rustin G, Gennings JN, Nelstrop AE, Covarrubias, Lambert HE, Bagshawew KD (1989) Use of CA-125 to predict survival of patients with ovarian karzi-noma. J Clin Oncol 7: 1667–1671
Takeshima N, Hirai Y, Katase K, Yano K, Yamauchi K, Hasumi K (1998) The value of squamous cell karzi-noma antigen as a predictor of nodal metastasis in cervical cancer. Gynecol Oncol 68: 263–266
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Münstedt, K., von Georgi, R. (2003). Die präoperative Tumormarkerbestimmung ist wichtig und richtig!. In: Gießener Gynäkologische Fortbildung 2003. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07492-3_32
Download citation
DOI: https://doi.org/10.1007/978-3-662-07492-3_32
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-04757-5
Online ISBN: 978-3-662-07492-3
eBook Packages: Springer Book Archive